Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Viral Infections of the Upper Respiratory Tract”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT03365687
What this trial is testing

Vitamin D In the Prevention of Viral-induced Asthma in Preschoolers

Who this might be right for
AsthmaAsthma ExacerbationsPreschool Child+5 more
Professor Francine Ducharme 323
Large-scale testing (Phase 3)Study completedNCT04526990
What this trial is testing

Phase III Trial of A COVID-19 Vaccine of Adenovirus Vector in Adults 18 Years Old and Above

Who this might be right for
COVID-19
CanSino Biologics Inc. 44,247
Not applicableActive Not RecruitingNCT04515446
What this trial is testing

Quantification of Viral Load in the Upper Respiratory Tract in Patients Treated With Olsetamivir for Influenza

Who this might be right for
Flu
Centre Hospitalier Universitaire de Nice 18
Testing effectiveness (Phase 2)Active Not RecruitingNCT07289542
What this trial is testing

Phase II Clinical Trial of Lyophilized Respiratory Syncytial Virus mRNA Vaccine in Adults Aged 50 Years or Above

Who this might be right for
Respiratory Syncytial Virus
Suzhou Abogen Biosciences Co., Ltd. 420
Testing effectiveness (Phase 2)WithdrawnNCT03026205
What this trial is testing

ARMS-I (a Formulation of Cetylpyridinium Chloride -CPC)

Who this might be right for
Viral Upper Respiratory Tract Infection
University of Toledo Health Science Campus
Testing effectiveness (Phase 2)UnknownNCT05522829
What this trial is testing

Evaluate the Immunogenicity and Safety of a Recombinant Protein COVID-19 Vaccine SCTV01E-1 in Population Aged Above 18 Years

Who this might be right for
COVID-19SARS-CoV-2 Infection
Sinocelltech Ltd. 400
Not applicableStudy completedNCT00405509
What this trial is testing

The Natural History of Viral Upper Respiratory Infections in Children Aged 6 to Less Than 14 Years

Who this might be right for
Upper Respiratory InfectionCommon Cold
West Penn Allegheny Health System 33
Testing effectiveness (Phase 2)Study completedNCT02254408
What this trial is testing

Presatovir in Hematopoietic Cell Transplant Recipients With Respiratory Syncytial Virus Infection of the Upper Respiratory Tract

Who this might be right for
Respiratory Syncytial Virus
Gilead Sciences 189
Not applicableLooking for participantsNCT07431840
What this trial is testing

Immune Defense Protein Impact On Respiratory Immune Outcomes

Who this might be right for
Upper Respiratory DiseaseInfluenzaViral Upper Respiratory Infection
Quantec Ltd 300
Early research (Phase 1)Study completedNCT05228613
What this trial is testing

Safety and Immunogenicity Study of COVID-19 Protein Subunit Recombinant Vaccine Adjuvanted With Alum+CpG 1018

Who this might be right for
COVID-19
PT Bio Farma 175
Testing effectiveness (Phase 2)Study completedNCT05921903
What this trial is testing

A Study on the Immune Response and Safety of an RSV Vaccine When Given to Adults 18 Years of Age and Above Who Received Lung or Kidney Transplant and Are at an Increased Risk of Respiratory Syncytial Virus Lower Respiratory Tract Disease and Compared to Healthy Adults 50 Years of Age and Above

Who this might be right for
Respiratory Syncytial Virus Infections
GlaxoSmithKline 386
Large-scale testing (Phase 3)Study completedNCT05559476
What this trial is testing

A Study on the Immune Response and Safety Elicited by a Vaccine Against Respiratory Syncytial Virus (RSV) When Given Alone and Together With a Vaccine Against Influenza in Adults Aged 65 Years and Above

Who this might be right for
Respiratory Syncytial Virus Infections
GlaxoSmithKline 1,029
Not applicableUnknownNCT05126550
What this trial is testing

The Immunogenicity, Safety, and Effectiveness of the COVID-19 Inactivated Vaccine

Who this might be right for
COVID-19
PT. Kimia Farma (Persero) Tbk 435
Not applicableStudy completedNCT04981535
What this trial is testing

Aerosol Particle From EGD in Patients With and Without Head Box in COVID-19 Era

Who this might be right for
EGDCovid19Aerosol Disease+1 more
King Chulalongkorn Memorial Hospital 190
Not applicableLooking for participantsNCT06286657
What this trial is testing

Xanthohumol and Viral Infections (XL)

Who this might be right for
Infection Viral
University of Vienna 100
Not applicableStudy completedNCT06020001
What this trial is testing

Clinical Evaluation of the AP203 Plant Extract Mixture in Adult Patients With Increased Incidence of Viral and/or Bacterial Upper Respiratory Tract Infections

Who this might be right for
Upper Respiratory Tract Infection Bacterial
AronPharma Sp. z o. o. 60
Testing effectiveness (Phase 2)Study completedNCT02451163
What this trial is testing

DBRCT on the Effect of Wheat Polysaccharides on Common Cold Infections in Elderly

Who this might be right for
Upper Respiratory InfectionsCommon Cold
Clinical Research Center Kiel GmbH 247
Large-scale testing (Phase 3)WithdrawnNCT01177852
What this trial is testing

Evaluation of Efficacy and Safety in Control Cough and the Relief of Nasal Symptoms in Children 2-12 Years Old,Suffering From Cough and Acute Rhinitis

Who this might be right for
InflammationCoughRhinitis
Ache Laboratorios Farmaceuticos S.A.
Large-scale testing (Phase 3)Study completedNCT04510207
What this trial is testing

Evaluate The Efficacy, Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccines (Vero Cell) in Healthy Population Aged 18 Years Old and Above

Who this might be right for
COVID-19
China National Biotec Group Company Limited 44,101
Testing effectiveness (Phase 2)UnknownNCT04990544
What this trial is testing

Phase II Clinical Trial of Recombinant SARS-CoV-2 Spike Protein Vaccine (CHO Cell) for the Prevention of COVID-19

Who this might be right for
COVID-19
Shanghai Zerun Biotechnology Co.,Ltd 528
Next Page